Organon (NYSE: OGN) GC gets 183,639 RSUs, now holds 92.6K shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Organon & Co. general counsel Kirke Weaver reported compensation-related equity activity. On March 31, 2026, Weaver received a grant of 183,639 Restricted Stock Units (RSUs), each representing a contingent right to one share of Organon common stock. These RSUs vest in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029.
On the same date, previously granted RSUs vested and were exercised into 18,513 shares of common stock. To cover tax obligations, 5,275 shares were withheld at a price based on the March 30, 2026 closing market price of $5.70 per share. After these transactions, Weaver directly owned 92,639.163 shares of Organon common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
18,513 shares exercised/converted
Mixed
7 txns
Insider
Weaver Kirke
Role
Gen. Counsel & Corp. Secy.
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 183,639 | $0.00 | -- |
| Exercise | Restricted Stock Units | 6,201 | $0.00 | -- |
| Exercise | Restricted Stock Units | 12,312 | $0.00 | -- |
| Exercise | Common Stock | 6,201 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,767 | $5.70 | $10K |
| Exercise | Common Stock | 12,312 | $0.00 | -- |
| Tax Withholding | Common Stock | 3,508 | $5.70 | $20K |
Holdings After Transaction:
Restricted Stock Units — 183,639 shares (Direct);
Common Stock — 85,602.163 shares (Direct)
Footnotes (1)
- The price is the closing market price of Organon & Co. ("Organon") common stock on Monday, March 30, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were granted. On March 31, 2026, the Reporting Person was granted 183,639 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029. Each RSU represents a contingent right to receive one share of Organon common stock. On March 31, 2023, the Reporting Person was granted 18,600 RSUs. Two-thirds of such RSUs previously vested, and the remaining one-third vested on March 31, 2026. On March 31, 2025, the Reporting Person was granted 36,937 RSUs. One-third of such RSUs vested on March 31, 2026, with the remaining two-thirds to vest on March 31, 2027 and March 31, 2028.
Key Figures
New RSU grant: 183,639 RSUs
RSU vesting schedule: 3 equal installments
RSUs exercised: 18,513 RSUs
+5 more
8 metrics
New RSU grant
183,639 RSUs
Granted March 31, 2026 to general counsel
RSU vesting schedule
3 equal installments
Vesting on March 31, 2027, 2028, and 2029
RSUs exercised
18,513 RSUs
Converted into common stock on March 31, 2026
Tax-withheld shares
5,275 shares
Withheld to cover tax obligations on March 31, 2026
Tax valuation price
$5.70 per share
Closing market price on March 30, 2026 used for RSU grant plan
Post-transaction holdings
92,639.163 shares
Organon common stock directly owned after transactions
2023 RSU grant
18,600 RSUs
Granted March 31, 2023; remaining one-third vested March 31, 2026
2025 RSU grant
36,937 RSUs
Granted March 31, 2025; one-third vested March 31, 2026
Key Terms
Restricted Stock Units, contingent right, tax-withholding disposition, exercise or conversion of derivative security, +1 more
5 terms
Restricted Stock Units financial
"On March 31, 2026, the Reporting Person was granted 183,639 RSUs"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each RSU represents a contingent right to receive one share"
tax-withholding disposition financial
"Payment of exercise price or tax liability by delivering securities"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
exercise or conversion of derivative security financial
"Exercise or conversion of derivative security"
closing market price financial
"The price is the closing market price of Organon & Co. common stock"
FAQ
What equity award did Organon (OGN) general counsel Kirke Weaver receive?
Kirke Weaver received a grant of 183,639 Restricted Stock Units (RSUs) on March 31, 2026. Each RSU represents a contingent right to receive one share of Organon common stock, increasing his potential future ownership as the units vest over time.
How will Kirke Weaver's 183,639 RSUs from Organon (OGN) vest?
The 183,639 RSUs will vest in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029. As each tranche vests, Weaver becomes entitled to receive the corresponding number of Organon common shares.
What earlier RSU grants to Kirke Weaver are referenced in this Organon (OGN) filing?
The filing notes RSU grants of 18,600 units on March 31, 2023 and 36,937 units on March 31, 2025. Portions of these earlier grants vested on March 31, 2026, contributing to the RSU exercises and resulting common stock reported.